Very early researchLooking for participantsNCT06632860
What this trial is testing
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Who this might be right for
Iodine-resistant Thyroid CancerMeningiomaNETs
Peking Union Medical College Hospital 40